Table 2 Variations of the main characteristics after one year of ETI.
V0 (n = 220) | V12 (n = 220) | p | |
---|---|---|---|
Iron deficiency (n, %) | 126 (58%) | 68 (31%) | 0.001 |
BMI (kg.m− 2, median [Q1;Q3]) | 20.8 [19; 22.9] | 22.1 [20.5; 23.7] | < 0.001 |
Diabetes (%) | 24% | 22% | ns |
Glycaemia (mmol/L) | 5.1 [4.6; 5.4] | 5 [4.6; 5.3] | ns |
PPI use (n, %) | 84 (38%) | 77 (35%) | 0.38 |
Pseudomonas aeruginosa colonization (n, %) | 143 (64%) | 95 (43%) | < 0.001 |
Haemoglobin (g/dL, median [Q1;Q3]) | 14.4 [13.1; 15.4] | 14.6 [13.6; 15.4] | ns |
Anaemia (n, %) | 27 (12.7%) | 11 (5.1%) | 0.006 |
Ferritin (µg/L, median [Q1;Q3]) | 46 [26.5; 85.5] | 53 [30.3; 97.8] | 0.002 |
TSAT (%) | 17 [12; 24] | 24 [17; 29.8] | < 0.001 |
CRP (mg/L) | 5.3 [2; 13.8] | 1 [0.4; 2.7] | < 0.001 |
Globulin (g/L) | 12.7 [10.6. 15] | 10.9 [9.4; 12.6] | < 0.001 |
Vitamin D (ng/mL) | 60.5 [39.3; 75.9] | 70 [51.3; 88] | < 0.001 |
FEV1p (%, median [Q1;Q3] | 59 [44; 77] | 80 [61; 96] | < 0.001 |
FEV1 (n, %) - > 69% - 50–69% - 30–49% - < 30% | 82 (38.5%) 60 (28.2%) 61 (28.6%) 10 (4.7%) | 141 (66.2%) 46 (21.6%) 23 (10.8%) 3 (1.4%) | < 0.001 |